Enzo Biochem (ENZ) News Today → Trump’s Former Wingman Bets Big on AI (From Banyan Hill Publishing) (Ad) Free ENZ Stock Alerts $1.09 0.00 (0.00%) (As of 05/14/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative March 28, 2024 | finanznachrichten.deIn Vitro Diagnostics Market Worth $119.4 billion | MarketsandMarketsMarch 18, 2024 | marketbeat.comEnzo Biochem, Inc. (NYSE:ENZ) Sees Large Decrease in Short InterestEnzo Biochem, Inc. (NYSE:ENZ - Get Free Report) was the target of a large decrease in short interest in the month of February. As of February 29th, there was short interest totalling 715,400 shares, a decrease of 9.8% from the February 14th total of 792,900 shares. Approximately 2.1% of the company's shares are sold short. Based on an average daily trading volume, of 113,500 shares, the short-interest ratio is presently 6.3 days.March 14, 2024 | finanznachrichten.deEnzo Biochem, Inc.: Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business UpdateMarch 14, 2024 | finance.yahoo.comEnzo Biochem (NYSE:ENZ) shareholders have endured a 69% loss from investing in the stock three years agoMarch 13, 2024 | finance.yahoo.comEnzo Biochem: Fiscal Q2 Earnings SnapshotMarch 13, 2024 | globenewswire.comEnzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business UpdateMarch 6, 2024 | marketbeat.comEnzo Biochem, Inc. (NYSE:ENZ) Short Interest UpdateEnzo Biochem, Inc. (NYSE:ENZ - Get Free Report) saw a significant growth in short interest during the month of February. As of February 15th, there was short interest totalling 792,900 shares, a growth of 5.1% from the January 31st total of 754,700 shares. Based on an average trading volume of 112,600 shares, the days-to-cover ratio is presently 7.0 days. Currently, 2.3% of the company's shares are short sold.February 17, 2024 | marketbeat.comEnzo Biochem (NYSE:ENZ) Stock Passes Above Two Hundred Day Moving Average of $1.38Enzo Biochem (NYSE:ENZ) Stock Price Crosses Above Two Hundred Day Moving Average of $1.38February 16, 2024 | money.usnews.comEnzo Biochem, Inc.February 14, 2024 | finance.yahoo.comJim Simons Trims Stake in Enzo Biochem IncFebruary 2, 2024 | msn.comEnzo Biochem Shareholders Elect Directors, Reject Exec PayFebruary 2, 2024 | msn.comEnzo Biochem Appoints New CEO and CFOFebruary 1, 2024 | finance.yahoo.comEnzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer AppointmentsJanuary 30, 2024 | finance.yahoo.comHere’s Why Laughing Water Capital Sold Enzo Biochem Inc (ENZ)December 16, 2023 | investorplace.comENZ Stock Earnings: Enzo Biochem Reported Results for Q1 2024December 15, 2023 | finance.yahoo.comENZO BIOCHEM REPORTS FIRST QUARTER FISCAL 2024 RESULTS AND PROVIDES BUSINESS UPDATEDecember 14, 2023 | finance.yahoo.comEnzo Biochem Inc (EZB.SG)December 13, 2023 | finance.yahoo.comImmunoassay Market is Expected to Reach $46.7 Billion | MarketsandMarkets.November 19, 2023 | morningstar.comEnzo Biochem Inc ENZNovember 8, 2023 | finance.yahoo.comGlobal Oxidative Stress Assays Market to Reach $1.9 Billion by 2030: Players Include Cell Biolabs, Enzo Biochem, Merck and MilliporeSigmaOctober 30, 2023 | finance.yahoo.comSteven J. Pully Appointed to Enzo Biochem’s Board of DirectorsOctober 30, 2023 | benzinga.comPoint of Care Molecular Diagnostics Market Worth $5.38 Billion by 2028 - Exclusive Report by The Insight PartnersOctober 26, 2023 | msn.comEnzo Biochem: Cleaned Up And Cash-Rich But UnlovedOctober 23, 2023 | finance.yahoo.comEsoteric Testing Market to grow by USD 18.87 billion from 2022-2027, North America to account for 36% of market growth - TechnavioOctober 6, 2023 | finance.yahoo.comEnzo Biochem (NYSE:ENZ) shareholders have endured a 63% loss from investing in the stock five years agoSeptember 18, 2023 | finance.yahoo.comNeurological Biomarkers Market to grow by USD 6.92 billion from 2022 to 2027 | North America to account for 43% of market growth- TechnavioSeptember 11, 2023 | finance.yahoo.comNeuroscience Antibodies and Assays Market to grow by USD 1.83 billion from 2022 to 2027, North America to account for 46% of market growth- TechnavioSeptember 6, 2023 | marketwatch.comEnzo Biochem CEO Hamid Erfanian Resigns After Two YearsSeptember 6, 2023 | finance.yahoo.comEnzo Biochem Announces Departure of Hamid Erfanian and Appointment of Kara Cannon as Interim CEOAugust 25, 2023 | fool.comEnzo Biochem (NYSE: ENZ)July 31, 2023 | finance.yahoo.comHere’s Why Laughing Water Capital Made a Position in Enzo Biochem (ENZ)July 25, 2023 | finanznachrichten.deEnzo Biochem, Inc.: Enzo Biochem Completes Sale of Clinical Laboratory to LabcorpJuly 11, 2023 | seekingalpha.comEnzo Biochem cuts price for labs assets to LabcorpJune 22, 2023 | benzinga.comShort Volatility Alert: Enzo Biochem IncJune 15, 2023 | finanznachrichten.deEnzo Biochem, Inc.: Enzo Biochem Reports Third Quarter Fiscal Year 2023 Financial ResultsJune 15, 2023 | msn.comEnzo Biochem reports Q3 resultsJune 14, 2023 | benzinga.comEmerson Firm Investigates Enzo Biochem Data BreachJune 14, 2023 | finance.yahoo.comEnzo Biochem Reports Third Quarter Fiscal Year 2023 Financial ResultsJune 8, 2023 | finance.yahoo.comEnzo Biochem, Inc.'s (NYSE:ENZ) Popularity With Investors Is Under Threat From OverpricingJune 1, 2023 | yahoo.comEnzo Biochem says ransomware attack exposed clinical test data of 2.5 million patientsMay 31, 2023 | seekingalpha.comEnzo Biochem says ransomware attack exposed patient info, Social Security numbersMay 22, 2023 | finanznachrichten.deEnzo Biochem, Inc.: Enzo Biochem Reports Significant Progress towards Completing the Clinical Lab Asset SaleMay 22, 2023 | finance.yahoo.comEnzo Biochem Reports Significant Progress towards Completing the Clinical Lab Asset SaleMay 14, 2023 | finance.yahoo.comEnzo Biochem Insiders Added US$11m Of Stock To Their Holdings \May 13, 2023 | marketwatch.comNon-Alcoholic Steatohepatitis (NASH) Drugs Market Growth Forecast 2023-2031 with Size and ShareMay 4, 2023 | marketwatch.comGlobal Blood Screening Market by [2023-2029] with Revenue OutsourcingMay 3, 2023 | marketwatch.comWound Healing Assay Kits Market Analysis and Forecast to 2031May 3, 2023 | benzinga.comSHAREHOLDER ALERT: Weiss Law Investigates Enzo Biochem, Inc.April 28, 2023 | marketwatch.com2023-2030 Non-Radioactive Nucleic Acid Labeling Product Market Growth Developments with Latest UpdatesApril 28, 2023 | msn.comEnzo Biochem in Farmingdale to Lay Off 247 Employees Get Enzo Biochem News Delivered to You Automatically Sign up to receive the latest news and ratings for ENZ and its competitors with MarketBeat's FREE daily newsletter. Email Address How to Make 100X on the AI Boom (Ad)For over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market. Click for his six specific AI stock in the crosshairs ENZ Media Mentions By Week ENZ Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ENZ News Sentiment▼1.000.56▲Average Medical News Sentiment ENZ News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ENZ Articles This Week▼10▲ENZ Articles Average Week Get Enzo Biochem News Delivered to You Automatically Sign up to receive the latest news and ratings for ENZ and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Personalis News Today Exagen News Today DermTech News Today Psychemedics News Today Biodesix News Today Eledon Pharmaceuticals News Today AVROBIO News Today Envoy Medical News Today IceCure Medical News Today BioLineRx News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ENZ) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Crypto 9-5 Escape PlanCrypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmithBuy this small stock before coming AI Tidal WaveChaikin AnalyticsCharles Payne Demystifies OptionsUnstoppable ProsperityRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap Sniper Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enzo Biochem, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
